Systemic Lupus Erythematosus : Books & Journals
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
 |
Systemic lupus erythematosus (SLE) is a diverse autoimmune rheumatic disease principally affecting women during childbearing years. The female-to-male ratio is around 9:1.
|
 |
Systemic lupus erythematosus is an autoimmune connective-tissue disorder with a wide range of clinical features, which predominantly affects women, especially from certain ethnic groups. Diagnosis is based on clinical assessment supported by investigations, including the finding of autoantibodies.
|
 |
Management of systemic lupus erythematosus (SLE) is a challenge because no interventions can result in cure, exacerbations of disease can occur after months of stable maintenance treatment, and undesirable side effects of the therapies can be as troublesome as the disease. Careful and frequent monitoring of patients is important in selecting management plans, monitoring efficacy, and changing treatments.
|
|
The following Clinical Topic Tour provides an overview of systemic lupus erythematosus (SLE) and was adapted from materials published by the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.